Authors
Latest:
Is Your Texting as Caring as Your Bedside Manner?Test your knowledge to see if your patients would consider you an efficient texter.
Latest:
The Crystal Ball: What This Means for the Future of Atopic Dermatitis TreatmentsPeter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
Latest:
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin AcademyLópez-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Latest:
The Many Considerations of Managing Generalized Pustular PsoriasisExperts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Latest:
When to Call a Time Out on Mohs SurgeryJerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
Latest:
Looking Ahead to the Future of DermatologyAs SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.
Latest:
Award-Winning Research on Hair Loss Consensus Highlighted at Annual MeetingThe poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
Case 2: Female, 62 Years OldAn expert in dermatology discusses the case of an active 62-year-old female, who is self-conscious about her condition, and explores how the panel would advise her to maintain her outdoor lifestyle while discussing effective topical treatments.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
Take-home Points to Manage AcneDrs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Latest:
Shingles Vaccination Counseling During the COVID-19 PandemicCDC advises not to delay shingles vaccination.
Latest:
Katie Martin, PA-C, Share Insights Into Aesthetic Innovations in 2023 and What’s to Come in 2024The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
Latest:
Parents Worries About Severe Acne’s Impact on TeensMore than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
What You Don’t Know and Should Know About PasswordsJ.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Latest:
Practice Management Pearls From ACAAI: Tips for Going GreenTodd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
Latest:
FDA Approves Relatlimab Plus Nivolumab for Unresectable or Metastatic MelanomaThe FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
Latest:
A Hairy Q&A With Jerry Shapiro, MDThe hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.
Latest:
Impacts of the Inflation Reduction Act on DoctorsHow will new federal law affect lives and wallets of physicians?
Latest:
Biosimilars for Humira Are on Their WayIn 2023 as many as 11 biosimilars to Humira are headed for the US market.
Latest:
Amy S. Paller, MD: PEDISTAD Trial Explores Bone Health in Children With Atopic DermatitisPaller shares early findings from the award winning poster on PEDISTAD trial and its clinical implication for children with atopic dermatitis.
Latest:
LEO Pharma Announces Positive Results for Delgocitinib Cream for Chronic Hand EczemaDelgocitinib is first-in-class pan-Janus kinase inhibitor.
